Pipat Piewngam, PhD

Life’s an adventure, Making the most of every chapter

[Pipat Piewngam, PhD @Patto_MiCro]

I am trilled and really happy to share our work from my postdoc training in The Lancet Microbes.

We showed that probiotic Bacillus can reduce the number of dangerous bacteria, Staphylococcus aureus, in the gut AND in the nose!!!! (1)

https://t.co/HQJ1EMeJNl

[Nicholas A. Christakis @NAChristakis]

The bacteria in your gut depend on where you are in the social network.

And the microbes within us treat our social networks as the extended environment in which they thrive. They can spread from person to person.

New #HNL work out today in @Nature. 1/

[Pipat Piewngam, PhD @Patto_MiCro]

@felixrl_ @NatureMicrobiol Congratulations 🍾

[Nature Cancer @NatureCancer]

News & Views by Sigrid Ruuls & Paul Parren

"Antibody avidity meets multiple myeloma"

🔗https://t.co/uyugMRQGon

[JAMA @JAMA_current]

Ivonescimab plus chemotherapy improved progression-free survival in patients with non-small cell lung cancer who progressed on treatment with EGFR-TKIs.

#ASCO24

https://t.co/7j1GAr3r9L

[Summit Therapeutics @SMMT_TX]

Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China

https://t.co/jweKtp0w9T

[Yakup Ergün @dr_yakupergun]

Top 10 Lung Cancer Summaries to be Presented at #ASCO24

Created by a fantastic team from the @OncoAlert network👇

@BiagioRicciutMD @HHorinouchi @FernandoOnco @lungoncdoc
& @weoncologists

[Pipat Piewngam, PhD @Patto_MiCro]

เอาไปประมูล เอาไปขาย แล้ว��ู้บริโภคเป็นอะไรขึ้นมา ใครรับผิดชอบ?

[Pipat Piewngam, PhD @Patto_MiCro]

ประเทศไทยขับเคลื่อนด้วย “ด้วยความรู้สึก” และ “ความพึงพอใจ” ข้าวเก่า 10 ปี เอามาล้างน้ำ 15 น้ำ กำจัดมอด กำจัดสิ่งสกปรกต่างๆ แล้วหุงกินออกสื่อ ยิ้มแย้ม ขำขัน บอกว่ากินได้ แต่จะดีกว่าไหม ถ้ามีการตรวจสอบ “ทางวิทยาศาสตร์” เพื่อดูว่า มีสารปนเปื้อนไหม,คุณค่าทางอาหารเหลือไหม อะไรก็ว่าไป

[Pipat Piewngam, PhD @Patto_MiCro]

Thrilled to share the publication of our latest research paper in Lancet Microbe! 📚🔬 Our team at NIAID, NIH has delved into the intricate world of Staphylococcus aureus colonization and devised innovative strategies for decolonization.

https://t.co/srjHTe8JY3

[Pipat Piewngam, PhD @Patto_MiCro]

Hot item ในอเมริกา ณ ตอนนี้ นั่นก็คือ #ขนมครก มีจำหน่ายที่ Trader Joe's บางสาขาของข��ดตลาดแล้วว

#SoftPower สำหรับ ประเทศไทยอย่างแท้จริง

[Pipat Piewngam, PhD @Patto_MiCro]

@MatthewD_Park @Nelson_LaMarche @MiriamMerad @SinaiImmunol Congrats 🍾

[Pipat Piewngam, PhD @Patto_MiCro]

What a cool study!

[Liwen Deng @Liwen_Deng811]

Excited to share our story about S. aureus and itch!

https://t.co/2fc2v3bvD8

[H. Jack West, MD, FASCO @JackWestMD]

🚨 Big changes afoot!

I'm proud to announce that I've joined Summit Therapeutics (@Summitplc) as VP of Clinical Development! I look forward to my colleagues learning more about the company & ivonescimab.

No more commentary from me on new data, but I'll contribute as I can.

[Pipat Piewngam, PhD @Patto_MiCro]

@zanyzarr @Georgetown Congratulations 🎉

[The Nobel Prize @NobelPrize]

“Ten years ago I was kicked out and forced to retire.”

Our new medicine laureate Katalin Karikó (@kkariko) told us how much it means to be awarded the Nobel Prize after a scientific career that has been full of challenges.

Ten years ago, Karikó was still doing all her experiments by hand but today she has been awarded the medicine prize for her research on mRNA, which led to the development of COVID-19 vaccines.

Listen now:

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

[Lorenzo Hall @LorenzoHall]

Quite the lightning show in DC ⚡️ …

[Pavin @PavinKyoto]

นายกต้องชื่อพิธาเท่านั้น ต้องไม่มีการต่อรองใดๆ ทั้งสิ้น #พิธานายกคนที่30

[St. Jude Research @StJudeResearch]

We proudly welcome Dr. Victor J. Torres as chair of the newly formed St. Jude Department of Host-Microbe Interactions, which will focus on treating and preventing disease-causing infections in children. https://t.co/MBitRYWuNM @TorresVJ_Lab

[Moshe Elkabets - Elkabets lab @Elkabetslab]

1/ 🚀 Exciting breakthrough in cancer immunotherapy! Our (together with Porgadors' lab) study published in @ScienceAdvances presents a novel #diagnostic #technology for predicting anti-PD1 treatment response in cancer patients. https://t.co/qzxswa5IZD